Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | ATF2 |
| Upstream (Parents) |
|---|
| (<<) ADAM10 → ATF2 |
| (<<) BZW1 → ATF2 |
| (<<) CREB1 → ATF2 |
| (<<) ETS1 → ATF2 |
| (<<) GNA13 → ATF2 |
| (<<) MAP3K2 → ATF2 |
| (<<) MAPK1 → ATF2 |
| (<<) MCL1 → ATF2 |
| (<<) POLR1B → ATF2 |
| (<<) PRPF4B → ATF2 |
| (<<) RAB5A → ATF2 |
| (<<) SMURF1 → ATF2 |
| (<<) YWHAB → ATF2 |
| Downstream (Children) |
|---|
| ATF2 → B3GNT2 (>>) |
| ATF2 → BCL2L13 (>>) |
| ATF2 → CPD (>>) |
| ATF2 → CRKL (>>) |
| ATF2 → CTNNB1 (>>) |
| ATF2 → DDX18 (>>) |
| ATF2 → EWSR1 (>>) |
| ATF2 → GDNF (>>) |
| ATF2 → GNB2L1 (>>) |
| ATF2 → KHDRBS1 (>>) |
| ATF2 → KRT34 (>>) |
| ATF2 → LTA4H (>>) |
| ATF2 → MAT2A (>>) |
| ATF2 → PARP10 (>>) |
| ATF2 → PRKCI (>>) |
| ATF2 → RDX (>>) |
| ATF2 → RYK (>>) |
| ATF2 → SOS2 (>>) |
| ATF2 → UBE2D4 (>>) |
| ATF2 → VAV3 (>>) |
| ATF2 → YWHAE (>>) |
